Cresco Labs Inc CL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Cresco Labs Announces Filing of Management Information Circular for Annual General and Special Meeting
-
Cresco Labs Appoints Edward Tilly to Board of Directors
-
Cresco Labs Acquires Nine Pennsylvania Dispensaries in Accretive Transaction to Strengthen Market Leadership
-
Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA
-
Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026
Trading Information
- Previous Close Price
- CA$0.94
- Day Range
- CA$0.89–0.94
- 52-Week Range
- CA$0.88–3.12
- Bid/Ask
- CA$0.88 / CA$0.93
- Shares Outstanding
- 370.24M
- Market Cap
- CA$340.62M
- Volume/Avg
- 87,930 / 75,572
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.42
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,900
- Website
- https://www.crescolabs.com
Valuation
|
Metric
|
CL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.67 |
Price/Sales | 0.42 |
Price/Cash Flow | 7.12 |
Price/Earnings
CL
Financial Strength
|
Metric
|
CL
|
|---|---|
Quick Ratio | 0.53 |
Current Ratio | 1.78 |
Interest Coverage | −0.72 |
Quick Ratio
CL
Profitability
|
Metric
|
CL
|
|---|---|
Return on Assets (Normalized) | −0.11% |
Return on Equity (Normalized) | −0.35% |
Return on Invested Capital (Normalized) | 5.49% |
Return on Assets
CL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|QlV%&S&G | LOCK|<d?mt | $66B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|^Fyvv%@Q | LOCK|cYVgl | $45B | |||
| Haleon PLC ADR
HLN
| LOCK|^JNqbz | LOCK|&c | $40B | |||
| Zoetis Inc Class A
ZTS
| LOCK|&!Hb%Ld< | LOCK|Vc | $30B | |||
| Viatris Inc
VTRS
| LOCK|KTj@&X | LOCK|T%< | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|v! | LOCK|Gs | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|SBJ$<Y< | LOCK|#> | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|#fnDWN | LOCK|Jz! | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|@c<>MXc | LOCK|#RM&F | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|Qf>Rs<q | LOCK|$> | $2B |
United States